Related Experiment Video
Updated: Feb 20, 2026

SUMO-Binding Entities SUBEs as Tools for the Enrichment, Isolation, Identification, and Characterization of the SUMO Proteome in Liver Cancer
Published on: November 1, 2019
SUMO-specific protease 2-mediated deSUMOylation is required for NDRG2 stabilization in gastric cancer cells
Xiao-Yan Hu1, Zhe Liu2, Kai-Lin Zhang3
1Department of Gastrointestinal Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
Abstract:
N-myc downstream regulated gene 2 (NDRG2) is frequently down-regulated in various cancers and functions as a candidate tumor suppressor gene. NDRG2 has been shown to be SUMOylated on the lysine 333 residue, which promoted its ubiquitination and sequentially degradation by the SUMO-targeted ubiquitin E3 ligase RNF4. However, how to regulated NDRG2 deSUMOylation process remains largely unknown. Here, we report that Sentrin/SUMO specific protease (SENP2) was down-regulated in clinic gastric cancer samples and possessed a tumor-suppressive role in gastric cancer. At the molecular level, we found that SENP2 interacts with NDRG2 and mediates the de-SUMOylation process of NDRG2. Overexpression of SENP2 stabilized NDRG2, whereas silencing SENP2 caused rapid NDRG2 SUMOylation and degradation, indicating SENP2 antagonizes NDRG2 ubiquitination and degradation, thereby promoting the stability and function of this protein. Thus, our study reveals that SENP2 acts as a tumor suppressor which is deregulated in gastric cancer and the specific de-SUMOylation activity of SENP2 for NDRG2 is critical for it stabilization as well as gastric cancer cells proliferation.
Insights
Sentrin/SUMO specific protease 2 (SENP2) stabilizes the tumor suppressor N-myc downstream regulated gene 2 (NDRG2) by removing SUMOylation tags. This process is crucial for inhibiting gastric cancer cell proliferation.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- N-myc downstream regulated gene 2 (NDRG2) is a tumor suppressor frequently downregulated in cancers.
- NDRG2 degradation is promoted by SUMOylation at lysine 333, leading to ubiquitination and proteasomal breakdown.
- The regulation of NDRG2 deSUMOylation remains poorly understood.
Purpose of the Study:
- To investigate the role of Sentrin/SUMO specific protease 2 (SENP2) in gastric cancer.
- To elucidate the molecular mechanism by which SENP2 affects NDRG2 stability and function.
Main Methods:
- Analysis of SENP2 expression in clinical gastric cancer samples.
- Co-immunoprecipitation assays to confirm protein-protein interactions.
- Western blotting to assess NDRG2 SUMOylation, ubiquitination, and degradation levels.
- Cell proliferation assays to evaluate the functional impact of SENP2.
Main Results:
- SENP2 is downregulated in gastric cancer tissues and exhibits tumor-suppressive activity.
- SENP2 directly interacts with NDRG2 and mediates its deSUMOylation.
- SENP2 overexpression stabilizes NDRG2, while SENP2 depletion leads to NDRG2 SUMOylation and degradation.
- SENP2 antagonizes NDRG2 ubiquitination and proteasomal degradation, enhancing NDRG2 stability.
Conclusions:
- SENP2 functions as a tumor suppressor in gastric cancer by stabilizing NDRG2.
- SENP2-mediated deSUMOylation of NDRG2 is critical for maintaining NDRG2 stability and inhibiting gastric cancer cell proliferation.
Related Concept Videos
GPCR Desensitization
Protein Modifications in the RER
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
Abnormal Proliferation
Protein Folding Quality Check in the RER
Export of Misfolded Proteins out of the ER
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...

